Advocacy Committee

EULAR Advocacy Committee

The EULAR Advocacy Committee engages with the EU as well as other national political institutions as a recognised partner and source of expertise in rheumatic and musculoskeletal diseases. The Committee fights for the recognition of the needs of people with rheumatic and musculoskeletal diseases (RMDs) by advocating research and education in rheumatology, promoting the EULAR brand as a reliable source of information, coordinating the work of the Sub-Committee(s) (Communication), and providing strategic guidance on all EULAR messages to internal and external audiences.

Advocacy Committee By-Laws

Communications Sub-Committee By-Laws

Communications Sub-Committee Regulations

Chair: Prof. Loreto Carmona, Spain
Chair-elect: Prof. Margreet Kloppenburg, Netherlands
Advisor: Prof. Gerd Burmester, Germany & Prof. Annamaria Iagnocco, Italy
Consultant: Rory Douglas Home & Frans Green
Sub-Committee Chair: Anna Voormann, Germany

Committee Members

Loreto Carmona, Spain
Margreet Kloppenburg, Netherlands
Gerd Burmester, Germany
Annamaria Iagnocco, Italy
Anna Voormann, Germany
Andri Phoka, Cyprus
Sina Bugeja, Malta
Fernando Estevez-Lopez, Spain
Thea Vliet-Vlieland, Netherlands
Xabier Michelena Vegas, Spain
Olena Zimba, Poland
Jelena Vojinovic, Serbia
Philipp Sewerin, Germany
Ayhan Dinc, Turkey
Razvan Ionescu, Romania
Lidia Teixeira, Portugal
Zoltan Szekanecz, Hungary
Elena Nikiphorou, United Kingdom
Ricardo Ferreira, Portugal
Oliver Hendricks, Denmark
Pia Isomaki, Finland
Rikke Moe, Norway
Laure Gossec, France

EULAR Communications Sub-Committee

The Communications Sub-Committee supports EULAR's and the Committee's objective and has the following aims:

provide strategic advice on EULAR communications, such as the EULAR communication plan, website and other digital communications, PR campaigns, EULAR App and emerging products;
provide strategic advice on all aspects regarding the official EULAR publications (Annals of the Rheumatic Diseases), such as policies in academic publishing, advertising, applications for Editor of journal, contract with the publisher, ethical policies (e.g. duplicate publication, plagiarism, conflict of interest, etc.).

The Sub-Committee does not pursue gainful or self-help purposes.

Sub-Committee Chair: Anna Voormann, Germany

Sub-Committee Members

Deshire Alpizar, Mexico
Francis Berenbaum, France
Johannes Bijlsma, Netherlands
Nele Caeyers, Belgium
Mrinalini Dey, United Kingdom
Oliver Hendricks, Denmark
Helena Marzo-Ortega, United Kingdom, Spain
Rikke Moe, Norway
Edoardo Prediletto, United Kingdom
Paul Studenic, Austria

Related Information

EULAR Advocacy Newsletter

EULAR is committed to bringing rheumatic and musculoskeletal diseases (RMDs) onto the EU's agenda. Sign up to the EULAR Advocacy newsletter to keep up with the changes that our organisation is working towards in the area of policy and legislation to help achieve better social and economic outcomes for the many millions of people affected by these chronic and debilitating diseases across Europe.

Subscribe now

EULAR Project Proposals

All EULAR project proposals are to be submitted by 15 January or 01 July of each year and is subject to the approval of the EULAR Council. The final decision and budget of a project will be determined by the EULAR Council each March and September.
Download the EULAR Project Proposal template
Submit your proposal to:
eular@eular.org

About EULAR Advocacy

EU Advocacy is a key activity for a European umbrella organisation like the European Alliance of Associations for Rheumatology (EULAR).

EULAR Advocacy Partnerships

EULAR is committed to partner with organisations and scientific medical societies at a EU and national level towards improving research funding, social policy legislation and quality of care; assisting advocacy actions on the national and international levels around rheumatic and musculoskeletal diseases (RMDs).

EULAR Advocacy Activities and Materials

In order to persuade governmental and EU key decision-makers supporting the European rheumatology community, EULAR Advocacy develops evidence-based materials about RMDs and communicates its position on key policies and legislation being discussed.

EULAR Policy Statements

As part of its advocacy activities, EULAR produces and adopts a number of documents and declarations that are used to express EULAR’s position and/or demands on different policy issues.

EU Parliament Interest Group on RMDs

The European Parliament Interest Group on Rheumatic and Musculoskeletal Diseases (RMDs) was created in 2009 on the occasion of World Arthritis Day (12 October) and was re-established during the current parliamentary term (2014-2019).